SCHEMBL20161669

SCHEMBL20161669

CCOC(=O)CC1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.38
MGAM O43451 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
ALDH1A1 P00352 2/20 0.35
TRPA1 O75762 1/20 0.35
FUCA1 P04066 2/20 0.34
ADK P55263 1/20 0.32
TLR4 O00206 1/20 0.32
PYGB P11216 2/20 0.32
CYP1A2 P05177 1/20 0.32
PRKD3 O94806 1/20 0.31
PRKCG P05129 1/20 0.31
PRKCB P05771 1/20 0.31
PRKCA P17252 1/20 0.31
PRKCH P24723 1/20 0.31
PRKCI P41743 1/20 0.31
PRKCE Q02156 1/20 0.31
PRKCQ Q04759 1/20 0.31
PRKCZ Q05513 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9577787 0.85 GAA (0.46) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL20161572 0.83 PYGB (0.45) GAAPYGBCA9CA12CA2
SCHEMBL20161941 0.83 PYGB (0.45) GAAPYGBCA9CA12CA2
SCHEMBL20161314 0.82 NAAA (0.47) TLR4
SCHEMBL18214222 0.81 FUCA1 (0.34) ALDH1A1FUCA1
SCHEMBL23619235 0.78 ALDH1A1 (0.43) ALDH1A1FUCA1TLR4PRKD3PRKCG
SCHEMBL20161706 0.78 FUCA1 (0.33) FUCA1PYGBPRKD3PRKCGPRKCB
SCHEMBL9915194 0.77 FUCA1 (0.40) GAAFUCA1PYGBCA9CA12
SCHEMBL9914020 0.77 FUCA1 (0.40) GAAFUCA1PYGBCA9CA12
SCHEMBL9914017 0.77 FUCA1 (0.40) GAAFUCA1PYGBCA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11045411-B2 Process for treating keratin materials using amide, acid or ester c-glycoside derivatives, and cosmetic composition containing same L'OREAL (FR) 2021-06-29 US disclosed
US-20180133137-A1 PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME L'OREAL (FR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180133137-A1 PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME KRT18, CUTA, GLA GAA 271/4885MGAM 227/4885SI 155/4885
US-11045411-B2 Process for treating keratin materials using amide, acid or ester c-glycoside derivatives, and cosmetic composition containing same KRT18, CUTA, GLA GAA 271/4885MGAM 227/4885SI 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.